Home › Compare › ELIXF vs ORCC

ELIXF vs ORCC: Dividend Comparison 2026

ELIXF yields 5970.15% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ELIXF wins by $349757300762302.00M in total portfolio value
10 years
ELIXF
ELIXF
● Live price
5970.15%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$349757300762302.00M
Annual income
$338,600,487,421,434,700,000.00
Full ELIXF calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — ELIXF vs ORCC

📍 ELIXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodELIXFORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ELIXF + ORCC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ELIXF pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ELIXF
Annual income on $10K today (after 15% tax)
$507,462.69/yr
After 10yr DRIP, annual income (after tax)
$287,810,414,308,219,520,000.00/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, ELIXF beats the other by $287,810,414,308,219,520,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ELIXF + ORCC for your $10,000?

ELIXF: 50%ORCC: 50%
100% ORCC50/50100% ELIXF
Portfolio after 10yr
$174878650381151.00M
Annual income
$169,300,243,710,717,360,000.00/yr
Blended yield
96.81%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

ELIXF
No analyst data
Altman Z
-68.9
Piotroski
2/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ELIXF buys
0
ORCC buys
0
No recent congressional trades found for ELIXF or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricELIXFORCC
Forward yield5970.15% ✓9.79%
Annual dividend / share$2.00 ✓$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0% ✓-50%
Portfolio after 10y$349757300762302.00M ✓$21.4K
Annual income after 10y$338,600,487,421,434,700,000.00 ✓$1.04
Total dividends collected$349006491373237.88M ✓$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: ELIXF vs ORCC ($10,000, DRIP)

YearELIXF PortfolioELIXF Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$607,715$597,014.93$11,190$489.61+$596.5K → ELIXF
2$34,558,188$33,907,932.79$12,229$256.01+$34.55M → ELIXF
3$1,839,034,548$1,802,057,287.52$13,216$130.74+$1839.02M → ELIXF
4$91,591,647,409$89,623,880,441.98$14,207$66.02+$91591.63M → ELIXF
5$4,269,634,661,039$4,171,631,598,311.20$15,234$33.17+$4269634.65M → ELIXF
6$186,311,225,789,697$181,742,716,702,385.70$16,317$16.62+$186311225.77M → ELIXF
7$7,611,116,385,606,142$7,411,763,374,011,165.00$17,468$8.32+$7611116385.59M → ELIXF
8$291,118,268,537,960,000$282,974,374,005,361,470.00$18,695$4.16+$291118268537.94M → ELIXF
9$10,426,928,355,950,688,000$10,115,431,808,615,070,000.00$20,006$2.08+$10426928355950.67M → ELIXF
10$349,757,300,762,302,000,000$338,600,487,421,434,700,000.00$21,407$1.04+$349757300762302.00M → ELIXF

ELIXF vs ORCC: Complete Analysis 2026

ELIXF — Stock

Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cannabis-related businesses, which are fully licensed for cultivation, production, and/or sale of medical and specialty cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. was incorporated in 2004 and is based in Montreal, Canada.

Full ELIXF Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this ELIXF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ELIXF vs SCHDELIXF vs JEPIELIXF vs OELIXF vs KOELIXF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.